Amigren capsules are used to fast simplification of a state at migraine attacks, with aura or without it.
Structure
Active ingredient - sumatriptan (a bottom the capsule supports a sumatriptan of succinate in terms of sumatriptan 50 mg).
Excipients: lactose, monohydrate; microcrystalline cellulose; sodium of a kroskarmelloz; magnesium stearate.
Structure of a cover of the capsule: gelatin, titan dioxide (E 171), ponso 4R (E 124).
Contraindication
- hypersensitivity to medicament components;
- a myocardial infarction in the anamnesis, coronary heart disease, Printsmetal's stenocardia, diseases of peripheral vessels or symptoms characteristic of coronary heart disease;
- a stroke or passing disturbance of cerebral circulation in the anamnesis;
- moderate or heavy arterial hypertension and slight uncontrollable arterial hypertension;
- heavy liver failure;
- simultaneous use of ergotamine or its derivatives (including metizergid);
- simultaneous use of any agonist of triptanes / 5-hydroksitriptamin-receptors (5-HT1);
- competitive prescribing of inhibitors monoamine oxidase (MAO) and medicament "Amigren"; the Amigren capsules should not be used within 2 weeks after cancellation of MAO inhibitors.
Route of administration
Capsule of the medicament "Amigren" cannot be applied for the purpose of prevention of an attack.
Amigren is recommended to be applied as soon as possible after the beginning of an attack of migraine though it is equally effective at each stage of an attack.
Recommended dose of the medicament "Amigren" for adults - 50 mg. In some cases the dose can be raised to 100 mg.
Amigren can be applied at new attacks of migraine, but if the first dose is inefficient, it is not necessary to use medicament repeatedly during the same attack.
If the patient reacted withto the first dose, but symptoms are restored, the second dose can be applied within the next 24 hours, at the same time the general daily dose should not exceed 300 mg.
should swallow ofCapsule entirely, washing down with water.
Feature of use
Pregnant
is not recommended to apply Amigren to pregnant women. In case of need it is necessary to weigh a ratio of the expected advantage for mother and possible risk for a fruit.
With care is applied during feeding by a breast. It is not recommended to nurse the child within 24 hours after administration of drug.
Children by this time the efficiency and safety of use of a sumatriptan for children are not established toby
therefore the medicament "Amigren" is not recommended to appoint this category of patients.
Drivers
Drowsiness can turn out to be consequence both migraines, and its Amigren medicament treatment therefore it is necessary to avoid control of motor transport or work with mechanisms during administration of medicament or an attack of migraine.
Overdose
Dose, the exceeding 400 mg (orally), did not make other side effects, except those which are provided below.
Treatment: performing maintenance therapy and observation of the patient not less than 10 hours.
Influence of a hemodialysis or peritoneal dialysis on the level of the medicament "Amigren" in blood plasma is not established to.
Side effects
from the immune system: reactions of hypersensitivity - from skin hypersensitivity to anaphylaxis cases.
from nervous system: dizziness; drowsiness; disturbances of sensitivity, including paresthesias and hypesthesias; spasms. Though some of these cases were noted at patients with spasms or with states which can bring to them, in the anamnesis, there are cases of development of spasms in patients without any tendency to them; tremor, dystonia, nystagmus, scotoma.
from mentality: excitement.
from a cardiovascular system: tranzitorny increase in arterial blood pressure right after administration of drug, blood inflow, bradycardia, tachycardia, the strengthened heartbeat, disturbance of a rhythm, passing ischemic changes on the ECG, a spasm of coronary arteries, stenocardia, a myocardial infarction, arterial hypotension, a Raynaud's disease.
from a respiratory system: asthma.
from a digestive tract: the nausea and vomiting arising at some patients, but their communication with use of a sumatriptan it is up to the end not found out; ischemic colitis, diarrhea.
from a musculoskeletal system: heavy feeling, myalgia. The given symptoms usually are passing, can have intensive character and influence any part of a body, including a thorax and a throat; muscle tension of a neck, arthralgia.
from an organ of sight: blinking, diplopia, decrease in visual acuity, loss of sight (usually passing). However disorders of vision can be a consequence of the attack of migraine.
from skin: hyperhidrosis.
Storage conditionsto Store
in original packing at a temperature not above 25 °C, out of children's reach.
Expiration date - 2 years.
Characteristics | |
Active ingredients | Sumatriptan |
Amount of active ingredient | 50 mg |
Applicant | Astrapharm |
Code of automatic telephone exchange | N02CC01 Sumatriptan |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | LTD COMPANY ASTRAFARM |
Quantity in packing | 10 capsules |
Release form | capsules for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Amigren |
Amigren kaps. 50 mg No. 10
- Product Code: 184051
- In Stock
- Ready to ship
-
$30.56